Last updated on December 2019

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in NSCLC Patients With EGFR Mutation Who Failed 1L or 2L EGFR TKI Therapy


Find a site near you

Start Over

Local Institution

Fukuoka, Japan
5.77miles
  Connect »

Local Institution

Fukuoka-shi, Japan
6.09miles
  Connect »